Sphera Funds Management Ltd. Lava Therapeutics Nv Transaction History
Sphera Funds Management Ltd.
- $380 Million
- Q1 2025
A detailed history of Sphera Funds Management Ltd. transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 48,420 shares of LVTX stock, worth $61,977. This represents 0.02% of its overall portfolio holdings.
Number of Shares
48,420
Previous 126,328
61.67%
Holding current value
$61,977
Previous $123,000
50.41%
% of portfolio
0.02%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding LVTX
# of Institutions
22Shares Held
4.93MCall Options Held
50.2KPut Options Held
200-
Redmile Group, LLC San Francisco, CA2.07MShares$2.66 Million0.28% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.96MShares$2.51 Million2.02% of portfolio
-
Bruce & Co., Inc. Chicago, IL522KShares$667,9980.28% of portfolio
-
Pathway Financial Advisors LLC103KShares$131,2000.03% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA65KShares$83,2000.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $33M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...